Musa is a technology company.
Musa is a waste management platform that integrates various waste management solutions, providing efficiency, transparency, and compliance with environmental regulations.
Musa has raised $20.0M across 3 funding rounds.
Musa has raised $20.0M in total across 3 funding rounds.
Musa has raised $20.0M in total across 3 funding rounds.
Musa's investors include Andreessen Horowitz, Bowery Capital, Creandum, EQT Partners, Flex Capital, Investo, Khosla Ventures, Silence, Immad Akhund, Justin Mateen, Roger Ehrenberg, Shervin Pishevar.
Musa Technology Partners, LLC (MUSA) is a managed IT services provider (MSP) founded in 2007, specializing in scalable technology platforms for life sciences, pharmaceuticals, medical devices, venture capital, and startups.[1][2][3] Headquartered in Waltham, Massachusetts, with around 73 employees and $6.5 million in revenue, MUSA offers services like cloud migration, virtualization, backup, on-site support, device provisioning, and FDA-compliant Validated Cloud hosting, enabling clients to focus on innovation rather than IT burdens.[1][2][3][4] Their mission centers on treating IT as a business enabler, not a cost center, particularly for high-growth sectors like biotech and tough tech, where they provide direct-to-engineer support, SOC2-compliant processes, and rapid scalability.[3][4]
MUSA originated in 2007 through a merger of IT firms, starting with general information technology roots before evolving into a specialized lab IT provider for life sciences.[1][2][3] This pivot leveraged deep industry experience to develop services like Validated Cloud—an FDA-compliant hosting solution—and the Lab Support Program, which combines remote, on-site, and hosted application support for turn-key compliance.[1] Over nearly two decades, MUSA refined its model through constant improvement, expanding from core IT to comprehensive MSP offerings for startups scaling rapidly and established firms needing stabilization, backed by hundreds of years of collective team expertise.[3][4]
MUSA rides the wave of digital transformation in life sciences and startups, where regulatory compliance, cloud scalability, and hybrid IT are critical amid rising biotech funding and AI-driven drug discovery.[1][3][4][6] Timing aligns with post-pandemic acceleration in pharma R&D and venture-backed scaling, where inefficient IT can derail growth; MUSA's Validated Cloud and lab IT fill gaps for smaller firms lacking in-house expertise.[1] Market forces like cybersecurity demands, remote work, and SOC2 requirements favor their proactive, accredited model, influencing the ecosystem by stabilizing tech for "tough tech" innovators, enabling faster cures and sustainable tech deployment without compliance risks.[2][4]
MUSA is poised for expansion as life sciences funding surges and AI/automation reshape IT needs, potentially deepening integrations with emerging tools like advanced Veeam backups or Azure AI for labs.[1][4] Trends in edge computing, zero-trust security, and green IT will shape their path, amplifying influence in venture ecosystems by powering more portfolio companies through Series A+ scaling. Their engineer-led, compliance-first approach positions them to evolve from MSP to strategic growth partner, sustaining the edge that lets clients chase breakthroughs while MUSA handles the tech stack.
Musa has raised $20.0M across 3 funding rounds. Most recently, it raised $15.0M Series A in September 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2021 | $15.0M Series A | Andreessen Horowitz, Bowery Capital, Creandum, EQT Partners, Flex Capital, Investo, Khosla Ventures, Silence, Immad Akhund, Justin Mateen, Roger Ehrenberg, Shervin Pishevar, Susanna Campbell | |
| Sep 1, 2020 | $4.0M Seed | Investo, Silence, Immad Akhund, Justin Mateen | |
| Oct 1, 2019 | $1.0M Seed | Investo, Silence, Immad Akhund, Justin Mateen |